Exane Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-82,881
| Closed | -$8.04M | – | 121 |
|
|
2018
Q3 | $8.04M | Sell |
82,881
-32,305
| -28% | -$3.13M | 2.52% | 15 |
|
|
2018
Q2 | $10.9M | Sell |
115,186
-17,881
| -13% | -$1.68M | 4.7% | 6 |
|
|
2018
Q1 | $10.8M | Sell |
133,067
-28,122
| -17% | -$2.28M | 3.24% | 11 |
|
|
2017
Q4 | $14.4M | Buy |
161,189
+40,989
| +34% | +$3.65M | 4.46% | 10 |
|
|
2017
Q3 | $11.2M | Buy |
+120,200
| New | +$11.2M | 2.19% | 18 |
|
|
2017
Q1 | – | Sell |
-101,548
| Closed | -$8.41M | – | 39 |
|
|
2016
Q4 | $8.41M | Sell |
101,548
-28,990
| -22% | -$2.4M | 2.77% | 17 |
|
|
2016
Q3 | $12.1M | Sell |
130,538
-32,684
| -20% | -$3.02M | 3.79% | 10 |
|
|
2016
Q2 | $12.7M | Buy |
163,222
+17,402
| +12% | +$1.35M | 4.93% | 8 |
|
|
2016
Q1 | $12M | Buy |
+145,820
| New | +$12M | 6.26% | 5 |
|